2 Stocks Set to Capitalize on the Surging Weight Loss Drug Trend

  • 📰 Investingcom
  • ⏱ Reading Time:
  • 16 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 53%

Business News News

Business Business Latest News,Business Business Headlines

Stocks Analysis by The Tokenist (Timothy Fries) covering: Eli Lilly and Company, Novo Nordisk A/S. Read The Tokenist (Timothy Fries)'s latest article on Investing.com

With over a billion obese individuals globally and many obesity-related cancers and diabetes cases in the US, weight loss drugs have become a thriving commodity. This trend, accelerated by the power of social media, has spurred pharmaceutical companies to develop weight-reduction drugs, and some of them are doing very well. According to Morgan Stanley, the weight loss drug market is expected to reach $77 billion in 2030, and these two stocks will likely play a key role in the industry.

Should Wegovy obtain insurance coverage, its current cost of $1,349 per month would likely get reduced significantly, potentially further boosting Novo Nordisk’s profits and stock price. The company’s stock is already up over 38% year-to-date, thanks to the success of its diabetes drug Ozempic.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 450. in BUSİNESS

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

3 Stocks That Can Be Potential Short Squeeze PlaysStocks Analysis by The Tokenist (Timothy Fries) covering: Microsoft Corporation, Qualcomm Incorporated, GameStop Corp, Tesla Inc. Read The Tokenist (Timothy Fries)'s latest article on Investing.com
Source: Investingcom - 🏆 450. / 53 Read more »

2 Stocks Set to Capitalize on the Surging Weight Loss Drug TrendStocks Analysis by The Tokenist (Timothy Fries) covering: Eli Lilly and Company, Novo Nordisk A/S. Read The Tokenist (Timothy Fries)'s latest article on Investing.com
Source: Investingcom - 🏆 450. / 53 Read more »

Japanese stocks climb for second day as Hong Kong stocks dropSupported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with unparalleled accuracy.
Source: MarketWatch - 🏆 3. / 97 Read more »

Falling stocks, climbing mortgage rates: how 5% Treasury yields could roil marketsRelentless selling of U.S. government bonds has brought Treasury yields to their highest level in more than a decade and a half, roiling everything from stocks to the real estate market.
Source: Reuters - 🏆 2. / 97 Read more »

These 6 global stocks are nearing the dreaded 'death cross' chart patternCNBC Pro identified 6 stocks, from automakers to lithium miners, which are close to forming a death cross chart pattern.
Source: CNBC - 🏆 12. / 72 Read more »

Indonesian copper-gold company storms ranking of world’s 50 most valuable mining stocksNo 1 source of global mining news and opinion
Source: mining - 🏆 449. / 53 Read more »